DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and NestlÃ©. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include WÃ¶lbern EquityPartner GmbH (Hamburg), NRW Bank (DÃ¼sseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KÃ¶lnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.
Funding Rounds (3) - $33.2MUpdate
German Regional Investment Group
TVM Capital is a global venture and growth capital firm with a 25 year operating track record.
Danisco A/S produces and sells food ingredients and industrial bioproducts primarily in Europe,...
Providing growth capital to firms
Mulligan BioCapital is an investment firm dedicated to the life sciences with a specific focus on...
Cologne, D - 50829